In this regard, work in the MC38 murine tumor model has demonstrated that LAG‐3 synergizes with PD‐1 in the suppression of antitumor T cell responses and that dual blockade is often curative for established tumors resistant to either monotherapy.167. Here, LAG3 is linked to neoplasm.